{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T12:59:28Z","timestamp":1776949168361,"version":"3.51.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T00:00:00Z","timestamp":1643155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T00:00:00Z","timestamp":1643155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["13\/94\/10"],"award-info":[{"award-number":["13\/94\/10"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["13\/94\/10"],"award-info":[{"award-number":["13\/94\/10"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["13\/94\/10"],"award-info":[{"award-number":["13\/94\/10"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Arteriovenous fistulas are the ideal form of vascular access that allows provision of haemodialysis. Stenotic lesions caused by neointimal hyperplasia commonly occur resulting in patients requiring a fistuloplasty. This is effective but there is a high recurrence rate. We sought to investigate the effects of a fistuloplasty on monocyte populations. Blood samples were taken from patients before and after their fistuloplasty procedure. Samples were analysed using flow cytometry, ELISA and Luminex assays. Univariate cox regression was carried out to investigate associations with post fistuloplasty patency. At 1\u20132\u00a0days post fistuloplasty, the proportion of classical (CD14++CD16\u2212) monocytes decreased (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), whilst intermediate (CD14++CD16+) and non-classical (CD14+CD16+) monocytes increased (both <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01) in a cohort of 20 patients. A time course study carried out in 5 patients showed that this was due to an increase in absolute numbers of non-classical and intermediate monocytes. Higher levels of non-classical monocytes pre-fistuloplasty were associated with an increased risk for patency loss (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). We measured 41 soluble factors in plasma samples taken before a fistuloplasty in 54 patients, with paired post-fistuloplasty samples (1\u20132\u00a0days) available in 30 patients. After correcting for false discovery, the only factor with a significant change in level was IL-6 (<jats:italic>P<\/jats:italic>\u2009=\u20090.0003, q\u2009=\u20090.0124). In a further time-course study in 6 patients, peak level of IL-6 occurred 2\u20133\u00a0h post fistuloplasty. This study demonstrates that there is a systemic inflammatory response to the fistuloplasty procedure and that monocyte subsets and IL-6 may be important in the pathophysiology of restenosis.<\/jats:p>","DOI":"10.1038\/s41598-022-05062-9","type":"journal-article","created":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T11:02:34Z","timestamp":1643194954000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Circulating Interleukin-6 and CD16 positive monocytes increase following angioplasty of an arteriovenous fistula"],"prefix":"10.1038","volume":"12","author":[{"given":"Seran","family":"Hakki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily J.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1192-1353","authenticated-orcid":false,"given":"Michael G.","family":"Robson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,26]]},"reference":[{"key":"5062_CR1","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1681\/ASN.2004090748","volume":"16","author":"BC Astor","year":"2005","unstructured":"Astor, B. C. et al. Type of vascular access and survival among incident hemodialysis patients: The choices for healthy outcomes in caring for ESRD (CHOICE) study. J. Am. Soc. Nephrol. 16, 1449\u20131455 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"5062_CR2","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1148\/radiol.2322030714","volume":"232","author":"DK Rajan","year":"2004","unstructured":"Rajan, D. K., Bunston, S., Misra, S., Pinto, R. & Lok, C. E. Dysfunctional autogenous hemodialysis fistulas: Outcomes after angioplasty\u2013are there clinical predictors of patency?. Radiology 232, 508\u2013515 (2004).","journal-title":"Radiology"},{"key":"5062_CR3","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1148\/radiology.218.3.r01mr38711","volume":"218","author":"HI Manninen","year":"2001","unstructured":"Manninen, H. I. et al. Brachial arterial access: Endovascular treatment of failing Brescia-Cimino hemodialysis fistulas\u2013initial success and long-term results. Radiology 218, 711\u2013718 (2001).","journal-title":"Radiology"},{"key":"5062_CR4","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1016\/j.ejrad.2011.09.004","volume":"81","author":"S Heye","year":"2012","unstructured":"Heye, S. et al. Factors influencing technical success and outcome of percutaneous balloon angioplasty in de novo native hemodialysis arteriovenous fistulas. Eur. J. Radiol. 81, 2298\u20132303 (2012).","journal-title":"Eur. J. Radiol."},{"key":"5062_CR5","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1177\/1129729819845991","volume":"20","author":"S Manou-Stathopoulou","year":"2019","unstructured":"Manou-Stathopoulou, S. et al. Factors associated with outcome after successful radiological intervention in arteriovenous fistulas: A retrospective cohort. J. Vasc. Access 20, 716\u2013724 (2019).","journal-title":"J. Vasc. Access"},{"key":"5062_CR6","doi-asserted-by":"publisher","first-page":"160","DOI":"10.5152\/dir.2014.14348","volume":"21","author":"A Aktas","year":"2015","unstructured":"Aktas, A., Bozkurt, A., Aktas, B. & Kirbas, I. Percutaneous transluminal balloon angioplasty in stenosis of native hemodialysis arteriovenous fistulas: Technical success and analysis of factors affecting postprocedural fistula patency. Diagn. Interv. Radiol. 21, 160\u2013166 (2015).","journal-title":"Diagn. Interv. Radiol."},{"key":"5062_CR7","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1093\/ndt\/15.12.2029","volume":"15","author":"L Turmel-Rodrigues","year":"2000","unstructured":"Turmel-Rodrigues, L. et al. Treatment of stenosis and thrombosis in haemodialysis fistulas and grafts by interventional radiology. Nephrol. Dial. Transpl. 15, 2029\u20132036 (2000).","journal-title":"Nephrol. Dial. Transpl."},{"key":"5062_CR8","first-page":"369687","volume":"2014","author":"I Bountouris","year":"2014","unstructured":"Bountouris, I., Kristmundsson, T., Dias, N., Zdanowski, Z. & Malina, M. Is repeat PTA of a failing hemodialysis fistula durable?. Int. J. Vasc. Med. 2014, 369687 (2014).","journal-title":"Int. J. Vasc. Med."},{"key":"5062_CR9","doi-asserted-by":"crossref","unstructured":"Karunanithy, N. et al. A multicenter randomized controlled trial indicates that paclitaxel-coated balloons provide no benefit during angioplasty of arteriovenous fistulas. Kidney Int. (2021).","DOI":"10.1016\/j.kint.2021.02.040"},{"key":"5062_CR10","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1056\/NEJMoa1914617","volume":"383","author":"RA Lookstein","year":"2020","unstructured":"Lookstein, R. A. et al. Drug-coated balloons for dysfunctional dialysis arteriovenous fistulas. N. Engl. J. Med. 383, 733\u2013742 (2020).","journal-title":"N. Engl. J. Med."},{"key":"5062_CR11","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.2215\/CJN.14231217","volume":"13","author":"SO Trerotola","year":"2018","unstructured":"Trerotola, S. O., Lawson, J., Roy-Chaudhury, P., Saad, T. F. & Trial, L. A. C. Drug coated balloon angioplasty in failing AV fistulas: A randomized controlled trial. Clin. J. Am. Soc. Nephro. 13, 1215\u20131224 (2018).","journal-title":"Clin. J. Am. Soc. Nephro."},{"key":"5062_CR12","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1161\/01.CIR.0000097002.69209.CD","volume":"108","author":"HD Danenberg","year":"2003","unstructured":"Danenberg, H. D. et al. Liposomal alendronate inhibits systemic innate immunity and reduces in-stent neointimal hyperplasia in rabbits. Circulation 108, 2798\u20132804 (2003).","journal-title":"Circulation"},{"key":"5062_CR13","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1097\/00005344-200311000-00014","volume":"42","author":"HD Danenberg","year":"2003","unstructured":"Danenberg, H. D. et al. Systemic depletion of macrophages by liposomal bisphosphonates reduces neointimal formation following balloon-injury in the rat carotid artery. J. Cardiovasc. Pharm. 42, 671\u2013679 (2003).","journal-title":"J. Cardiovasc. Pharm."},{"key":"5062_CR14","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2215\/CJN.04030416","volume":"12","author":"CC Wu","year":"2017","unstructured":"Wu, C. C. et al. Monocyte chemoattractant protein-1 levels and postangioplasty restenosis of arteriovenous fistulas. Clin. J. Am. Soc. Nephro. 12, 113\u2013121 (2017).","journal-title":"Clin. J. Am. Soc. Nephro."},{"key":"5062_CR15","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.immuni.2010.08.012","volume":"33","author":"J Cros","year":"2010","unstructured":"Cros, J. et al. Human CD14(dim) monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity 33, 375\u2013386 (2010).","journal-title":"Immunity"},{"key":"5062_CR16","doi-asserted-by":"crossref","unstructured":"Maga, P. et al. Percutaneous transluminal angioplasty in patients with peripheral arterial disease does not affect circulating monocyte subpopulations. Biomed. Res. Int. (2016).","DOI":"10.1155\/2016\/2708957"},{"key":"5062_CR17","doi-asserted-by":"publisher","first-page":"e52406","DOI":"10.1371\/journal.pone.0052406","volume":"7","author":"SD West","year":"2012","unstructured":"West, S. D. et al. Transforming growth factor-beta, macrophage colony-stimulating factor and C-reactive protein levels correlate with CD14(high)CD16+ monocyte induction and activation in trauma patients. PLoS ONE 7, e52406 (2012).","journal-title":"PLoS ONE"},{"key":"5062_CR18","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/jcbfm.2009.25","volume":"29","author":"X Urra","year":"2009","unstructured":"Urra, X. et al. Monocyte subtypes predict clinical course and prognosis in human stroke. J. Cereb. Blood Flow Metab. 29, 994\u20131002 (2009).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"5062_CR19","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1111\/j.1538-7836.2011.04603.x","volume":"10","author":"LD Tapp","year":"2012","unstructured":"Tapp, L. D., Shantsila, E., Wrigley, B. J., Pamukcu, B. & Lip, G. Y. The CD14++CD16+ monocyte subset and monocyte-platelet interactions in patients with ST-elevation myocardial infarction. J. Thromb. Haemost. 10, 1231\u20131241 (2012).","journal-title":"J. Thromb. Haemost."},{"key":"5062_CR20","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/art.33418","volume":"64","author":"M Rossol","year":"2012","unstructured":"Rossol, M., Kraus, S., Pierer, M., Baerwald, C. & Wagner, U. The CD14(bright) CD16+ monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population. Arthritis Rheum. 64, 671\u2013677 (2012).","journal-title":"Arthritis Rheum."},{"key":"5062_CR21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.15252\/emmm.201707502","volume":"10","author":"T Getzin","year":"2018","unstructured":"Getzin, T. et al. The chemokine receptor CX3CR1 coordinates monocyte recruitment and endothelial regeneration after arterial injury. Embo. Mol. Med. 10, 151\u2013159 (2018).","journal-title":"Embo. Mol. Med."},{"key":"5062_CR22","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.atherosclerosis.2016.09.002","volume":"253","author":"M Wildgruber","year":"2016","unstructured":"Wildgruber, M. et al. Increased intermediate CD14(++)CD16(++) monocyte subset levels associate with restenosis after peripheral percutaneous transluminal angioplasty. Atherosclerosis 253, 128\u2013134 (2016).","journal-title":"Atherosclerosis"},{"key":"5062_CR23","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1161\/ATVBAHA.114.304172","volume":"34","author":"KS Rogacev","year":"2014","unstructured":"Rogacev, K. S. et al. Lower apo A-I and lower HDL-C levels are associated with higher intermediate CD14(++)CD16(+) monocyte counts that predict cardiovascular events in chronic kidney disease. Arterioscl. Throm. Vasc. 34, 2120\u20132127 (2014).","journal-title":"Arterioscl. Throm. Vasc."},{"key":"5062_CR24","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/j.jacc.2012.07.019","volume":"60","author":"KS Rogacev","year":"2012","unstructured":"Rogacev, K. S. et al. CD14++CD16+ monocytes independently predict cardiovascular events: A cohort study of 951 patients referred for elective coronary angiography. J. Am. Coll. Cardiol. 60, 1512\u20131520 (2012).","journal-title":"J. Am. Coll. Cardiol."},{"key":"5062_CR25","doi-asserted-by":"publisher","first-page":"e69409","DOI":"10.1371\/journal.pone.0069409","volume":"8","author":"M Kaito","year":"2013","unstructured":"Kaito, M. et al. Relevance of distinct monocyte subsets to clinical course of ischemic stroke patients. PLoS ONE 8, e69409 (2013).","journal-title":"PLoS ONE"},{"key":"5062_CR26","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1002\/1529-0131(200006)43:6<1233::AID-ANR6>3.0.CO;2-9","volume":"43","author":"D Baeten","year":"2000","unstructured":"Baeten, D. et al. Human cartilage gp-39+, CD16+ monocytes in peripheral blood and synovium: Correlation with joint destruction in rheumatoid arthritis. Arthritis Rheum. 43, 1233\u20131243 (2000).","journal-title":"Arthritis Rheum."},{"key":"5062_CR27","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1097\/00003246-200205000-00031","volume":"30","author":"ML Allen","year":"2002","unstructured":"Allen, M. L. et al. Early postoperative monocyte deactivation predicts systemic inflammation and prolonged stay in pediatric cardiac intensive care. Crit. Care Med. 30, 1140\u20131145 (2002).","journal-title":"Crit. Care Med."},{"key":"5062_CR28","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jtcvs.2005.01.008","volume":"130","author":"P Gessler","year":"2005","unstructured":"Gessler, P. et al. Monocyte function-associated antigen expression during and after pediatric cardiac surgery. J. Thorac. Cardiovasc. Surg. 130, 54\u201360 (2005).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"5062_CR29","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jcrc.2016.01.027","volume":"33","author":"TF Manzoli","year":"2016","unstructured":"Manzoli, T. F., Troster, E. J., Ferranti, J. F. & Sales, M. M. Prolonged suppression of monocytic human leukocyte antigen-DR expression correlates with mortality in pediatric septic patients in a pediatric tertiary Intensive Care Unit. J. Crit. Care 33, 84\u201389 (2016).","journal-title":"J. Crit. Care"},{"key":"5062_CR30","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s13054-016-1505-0","volume":"20","author":"AM Drewry","year":"2016","unstructured":"Drewry, A. M. et al. Comparison of monocyte human leukocyte antigen-DR expression and stimulated tumor necrosis factor alpha production as outcome predictors in severe sepsis: A prospective observational study. Crit. Care 20, 334 (2016).","journal-title":"Crit. Care"},{"key":"5062_CR31","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1097\/INF.0000000000001990","volume":"37","author":"NP Boeddha","year":"2018","unstructured":"Boeddha, N. P. et al. HLA-DR expression on monocyte subsets in critically Ill children. Pediatr. Infect. Dis. J. 37, 1034\u20131040 (2018).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"5062_CR32","doi-asserted-by":"publisher","first-page":"304","DOI":"10.5551\/jat.19414","volume":"21","author":"M Shoji","year":"2014","unstructured":"Shoji, M. et al. IL-6 mobilizes bone marrow-derived cells to the vascular wall, resulting in neointima formation via inflammatory effects. J. Atheroscler. Thromb. 21, 304\u2013312 (2014).","journal-title":"J. Atheroscler. Thromb."},{"key":"5062_CR33","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1084\/jem.20170355","volume":"214","author":"AA Patel","year":"2017","unstructured":"Patel, A. A. et al. The fate and lifespan of human monocyte subsets in steady state and systemic inflammation. J. Exp. Med. 214, 1913\u20131923 (2017).","journal-title":"J. Exp. Med."},{"key":"5062_CR34","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1056\/NEJMe2103108","volume":"384","author":"EJ Rubin","year":"2021","unstructured":"Rubin, E. J., Longo, D. L. & Baden, L. R. Interleukin-6 receptor inhibition in covid-19: Cooling the inflammatory soup. N. Engl. J. Med. 384, 1564\u20131565 (2021).","journal-title":"N. Engl. J. Med."},{"key":"5062_CR35","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1093\/rheumatology\/keq343","volume":"50","author":"L Campbell","year":"2011","unstructured":"Campbell, L., Chen, C., Bhagat, S. S., Parker, R. A. & Ostor, A. J. Risk of adverse events including serious infections in rheumatoid arthritis patients treated with tocilizumab: A systematic literature review and meta-analysis of randomized controlled trials. Rheumatology (Oxford) 50, 552\u2013562 (2011).","journal-title":"Rheumatology (Oxford)"},{"key":"5062_CR36","doi-asserted-by":"publisher","first-page":"5329","DOI":"10.1182\/blood-2012-02-412551","volume":"119","author":"M Korkosz","year":"2012","unstructured":"Korkosz, M., Bukowska-Strakova, K., Sadis, S., Grodzicki, T. & Siedlar, M. Monoclonal antibodies against macrophage colony-stimulating factor diminish the number of circulating intermediate and nonclassical (CD14(++)CD16(+)\/CD14(+)CD16(++)) monocytes in rheumatoid arthritis patient. Blood 119, 5329\u20135330 (2012).","journal-title":"Blood"},{"key":"5062_CR37","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s13063-016-1372-7","volume":"17","author":"N Karunanithy","year":"2016","unstructured":"Karunanithy, N. et al. Paclitaxel-coated balloon fistuloplasty versus plain balloon fistuloplasty only to preserve the patency of arteriovenous fistulae used for haemodialysis (PAVE): Study protocol for a randomised controlled trial. Trials 17, 241 (2016).","journal-title":"Trials"}],"updated-by":[{"DOI":"10.1038\/s41598-022-22213-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:00:00Z","timestamp":1667174400000}},{"DOI":"10.1038\/s41598-023-44596-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05062-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05062-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05062-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T21:38:33Z","timestamp":1699997913000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05062-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,26]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["5062"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-05062-9","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41598-022-22213-0","asserted-by":"object"},{"id-type":"doi","id":"10.1038\/s41598-023-44596-4","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,26]]},"assertion":[{"value":"6 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-022-22213-0","URL":"https:\/\/doi.org\/10.1038\/s41598-022-22213-0","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2023","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-023-44596-4","URL":"https:\/\/doi.org\/10.1038\/s41598-023-44596-4","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1427"}}